Stay updated with breaking news from 87837710. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
V Square Quantitative Management LLC raised its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 246.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,453 shares of the biotechnology company’s stock after acquiring an additional 2,457 shares during the quarter. […]
Victory Capital Management Inc. cut its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 19.9% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 31,360 shares of the biotechnology company’s stock after selling 7,783 shares during the period. […]
Dorsey & Whitney Trust CO LLC increased its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 1.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 155,984 shares of the biotechnology company’s stock after acquiring an additional 1,538 shares during the quarter. […]
Fox Run Management L.L.C. acquired a new position in Bio-Techne Co. (NASDAQ:TECH – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 5,898 shares of the biotechnology company’s stock, valued at approximately $401,000. Several other institutional investors and hedge funds have also […]
Bio-Techne (NASDAQ:TECH – Get Free Report) had its price objective dropped by equities researchers at Stephens from $92.00 to $87.00 in a research note issued on Friday, Benzinga reports. The firm presently has an “overweight” rating on the biotechnology company’s stock. Stephens’ target price would indicate a potential upside of 31.72% from the stock’s current […]